Boston Business Journal June 25, 2019 4:55 pm Boston Business Journal Report: Acer Therapeutics Stock Plummets 80% Life sciences reporter Allison DeAngelis joins necn to discuss her story, “Acer Therapeutics stock plummets 80 percent on FDA rejection.” US & World Videos 1:32 Amber Alert for 2 NH girls canceled, father in custody 2:53 Latest on Lewiston, Maine shootings 2:01 Local researchers looking to turn plastic into fuel 1:45 Gov. Healey to sign bottle ban order for state agencies 2:41 Leominster students return to school after floods
